Danco Statement on Filing of Cert Petition, September 8, 2023

NEW YORK, Sept. 8, 2023 /PRNewswire/ — Today, Danco filed a cert petition asking the Supreme Court to review the Fifth Circuit’s decision invalidating changes FDA approved to the conditions of use for Mifeprex® in 2016 and in 2021. That decision is inconsistent with established Supreme…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.